Health and Healthcare
Myriad Did What??? A Stock Split? (MYGN)
Published:
Last Updated:
How long has it been since a company announced a stock split? More importantly, when was the last from a fairly large company? I can’t recall that off the top of my head either. Mryiad Genetics, Inc. (NASDAQ: MYGN) just approved a 2-for-1 stock split.
The split will paid in the form of a dividend to holders of record on March 25, 2009 and payable on March 25, 2009. Myriad says that its shares outstanding will be roughly 95 million.
Myriad Genetics said that it also still intends to spin off its R&D business in the second quarter. Each share will still result in an additional half share of the Myriad Pharmaceuticals unit in the form of a dividend. The result will be one-quarter of a share in the spin-off after the payout via a tax-free distribution to holders.
Shares of Myriad closed up almost 2% at $82.22, and its 52-week trading range is $34.35 to $88.40.
Jon C. Ogg
February 24, 2009
The #1 Thing to Do Before You Claim Social Security (Sponsor)
Choosing the right (or wrong) time to claim Social Security can dramatically change your retirement. So, before making one of the biggest decisions of your financial life, it’s a smart idea to get an extra set of eyes on your complete financial situation.
A financial advisor can help you decide the right Social Security option for you and your family. Finding a qualified financial advisor doesn’t have to be hard. SmartAsset’s free tool matches you with up to three financial advisors who serve your area, and you can interview your advisor matches at no cost to decide which one is right for you.
Click here to match with up to 3 financial pros who would be excited to help you optimize your Social Security outcomes.
Have questions about retirement or personal finance? Email us at [email protected]!
By emailing your questions to 24/7 Wall St., you agree to have them published anonymously on a673b.bigscoots-temp.com.
By submitting your story, you understand and agree that we may use your story, or versions of it, in all media and platforms, including via third parties.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.
Latest from 24/7
